{"transactions":[{"id":2829306,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-26T17:27:45.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":21800,"derivative":{"exercise_price":16.99,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":21800},"source":{"system":"sec-edgar","filing":"0001192482-21-000190","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248221000190/edgar.xml","form_type":"4"}},{"id":2829305,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:27:45.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer."}],"balance_after":90887,"source":{"system":"sec-edgar","filing":"0001192482-21-000190","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248221000190/edgar.xml","form_type":"4"}},{"id":3372693,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant (right to buy)","published_at":"2019-11-13T20:50:46.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":12931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":12931,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":523},"source":{"system":"sec-edgar","filing":"0001192482-19-000423","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248219000423/edgar.xml","form_type":"4"}},{"id":3372692,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant (right to buy)","published_at":"2019-11-13T20:50:46.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":12931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":12931},"source":{"system":"sec-edgar","filing":"0001192482-19-000423","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248219000423/edgar.xml","form_type":"4"}},{"id":3372691,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series B Preferred Stock","published_at":"2019-11-13T20:50:46.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":315086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12760},"source":{"system":"sec-edgar","filing":"0001192482-19-000423","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248219000423/edgar.xml","form_type":"4"}},{"id":3372690,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Preferred Stock","published_at":"2019-11-13T20:50:46.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":197511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7999},"source":{"system":"sec-edgar","filing":"0001192482-19-000423","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248219000423/edgar.xml","form_type":"4"}},{"id":3372689,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-13T20:50:46.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":12760,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":78887,"source":{"system":"sec-edgar","filing":"0001192482-19-000423","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248219000423/edgar.xml","form_type":"4"}},{"id":3372688,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":142161,"kind":"person","name":"PERSENAIRE MAARTEN","position":1,"cik":"0001207313","reported_name":"PERSENAIRE MAARTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-13T20:50:46.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":7999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 15,572 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":66127,"source":{"system":"sec-edgar","filing":"0001192482-19-000423","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207313/000119248219000423/edgar.xml","form_type":"4"}}]}